Blood group-related antigens as markers of malignant potential and heterogeneity in human carcinomas.
The expression of BGR-Ags is often aberrant in human carcinomas. The observation that BGR-Ag expression in human bladder carcinomas correlates with prognosis for patients with these tumors is especially interesting in light of the numerous reports of correlations between cell surface glycosylation and malignant phenotype in experimental animal tumors. Many observations suggest how this relation might be mediated. It seems reasonable to anticipate that the study of the BGR-Ags and their expression in carcinoma may emerge from its current predominantly descriptive phase and become an important part of the investigation of human tumor biology.
D000951:Antigens, Neoplasm / Q000032:analysis*; D001789:Blood Group Antigens / Q000276:immunology*; D002277:Carcinoma / Q000276:immunology*; D005455:Fluorescent Antibody Technique; D006801:Humans; D007983:Lewis Blood Group Antigens; D013329:Structure-Activity Relationship; D001749:Urinary Bladder Neoplasms / Q000276:immunology*
D000951:Antigens, Neoplasm; D001789:Blood Group Antigens; D007983:Lewis Blood Group Antigens